Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis
K. Melissa Hallow, Yeshitila Gebremichael, Gabriel Helmlinger, et al.
AJP Renal Physiology (2017) Vol. 312, Iss. 5, pp. F819-F835
Open Access | Times Cited: 94

Showing 26-50 of 94 citing articles:

Recent advances in molecular mechanisms of acute kidney injury in patients with diabetes mellitus
Barbara Infante, Francesca Conserva, Paola Pontrelli, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 18
Knockout of Na+-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration
Panai Song, Winnie Huang, Akira Ōnishi, et al.
AJP Renal Physiology (2019) Vol. 317, Iss. 1, pp. F207-F217
Open Access | Times Cited: 54
Quantitative Systems Pharmacology: An Exemplar Model‐Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug Development
Gabriel Helmlinger, В. В. Соколов, Kirill Peskov, et al.
CPT Pharmacometrics & Systems Pharmacology (2019) Vol. 8, Iss. 6, pp. 380-395
Open Access | Times Cited: 51
Obesity and chronic kidney disease: prevalence, mechanism, and management
Hyung Eun Yim, Kee Hwan Yoo
Clinical and Experimental Pediatrics (2021) Vol. 64, Iss. 10, pp. 511-518
Open Access | Times Cited: 36
Childhood Obesity: Insight into Kidney Involvement
Nazareno Carullo, Mariateresa Zicarelli, Ashour Michael, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17400-17400
Open Access | Times Cited: 13
JinChan YiShen TongLuo Formula ameliorate mitochondrial dysfunction and apoptosis in diabetic nephropathy through the HIF-1α-PINK1-Parkin pathway
Qiyan Zheng, Xueqin Zhang, Jing Guo, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 117863-117863
Closed Access | Times Cited: 5
Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF
Alexander Peikert, Muthiah Vaduganathan, Finnian R. Mc Causland, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 5, pp. 794-803
Open Access | Times Cited: 22
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Kidney Disease and Beyond
Zein Alabdin Hannouneh, Carmen Elena Cervantes, Mohamad Hanouneh, et al.
Glomerular Diseases (2025) Vol. 5, Iss. 1, pp. 119-132
Open Access
Advances in understanding and managing diabetic kidney disease: An updated review
Elmukhtar Habas, Amnna Rayani, Aml Habas, et al.
Ukrainian Journal of Nephrology and Dialysis (2025), Iss. 1(85), pp. 66-80
Open Access
Renal olfactory receptor 1393 contributes to the progression of type 2 diabetes in a diet-induced obesity model
Blythe D. Shepard, Hermann Koepsell, Jennifer L. Pluznick
AJP Renal Physiology (2018) Vol. 316, Iss. 2, pp. F372-F381
Open Access | Times Cited: 37
Clinical Evidence and Proposed Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect?
Brent Deschaine, Sahil Verma, Hussein Rayatzadeh
Cardiac failure review (2022) Vol. 8
Open Access | Times Cited: 18
Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease
Shan Jiang, Hua Su
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro
Yuan Li, Weihong Long, Haifeng Zhang, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111844-111844
Closed Access | Times Cited: 3
Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines
Milton Packer
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Mitigation of the Adverse Consequences of Nutrient Excess on the Kidney: A Unified Hypothesis to Explain the Renoprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Milton Packer
American Journal of Nephrology (2020) Vol. 51, Iss. 4, pp. 289-293
Open Access | Times Cited: 26
Lipotoxic Proximal Tubular Injury: A Primary Event in Diabetic Kidney Disease
Hua Wang, Shu Zhang, Jia Guo
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 21
Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement
Ajitesh Roy, Animesh Maiti, Anirban Sinha, et al.
Diabetes Therapy (2020) Vol. 11, Iss. 12, pp. 2791-2827
Open Access | Times Cited: 21
Renal Tubular Handling of Glucose and Fructose in Health and Disease
Volker Vallon, Takahiko Nakagawa
Comprehensive physiology (2021), pp. 2995-3044
Open Access | Times Cited: 20
Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?
Milton Packer, Tariq Jamal Siddiqi, Javed Butler
European Heart Journal (2023) Vol. 44, Iss. 17, pp. 1522-1525
Open Access | Times Cited: 7
Redox-driven cardioprotective effects of sodium-glucose co-transporter-2 inhibitors: comparative review
Julia Hoehlschen, Dominik Hofreither, Tamara Tomin, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Model‐Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin
Jessica A. Brady, K. Melissa Hallow
The Journal of Clinical Pharmacology (2017) Vol. 58, Iss. 3, pp. 377-385
Closed Access | Times Cited: 24
Multiscale Mathematical Model of Drug-Induced Proximal Tubule Injury: Linking Urinary Biomarkers to Epithelial Cell Injury and Renal Dysfunction
Yeshitila Gebremichael, James Lu, Harish Shankaran, et al.
Toxicological Sciences (2017) Vol. 162, Iss. 1, pp. 200-211
Open Access | Times Cited: 22
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms
Naoki Kashihara, Kengo Kidokoro, Eiichiro Kanda
Current Opinion in Nephrology & Hypertension (2019) Vol. 29, Iss. 1, pp. 112-118
Closed Access | Times Cited: 20
The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes
Gwang Sil Kim, Joong Hyun Park, Jong Chul Won
Endocrinology and Metabolism (2019) Vol. 34, Iss. 2, pp. 106-106
Open Access | Times Cited: 19
Sodium bicarbonate loading limits tubular cast formation independent of glomerular injury and proteinuria in Dahl salt-sensitive rats
Sarah Ray, Bansari Patel, Debra L. Irsik, et al.
Clinical Science (2018) Vol. 132, Iss. 11, pp. 1179-1197
Open Access | Times Cited: 18

Scroll to top